Stocks Health care PBLS
NASDAQ · Health careParabilis Medicines, Inc. (PBLS)
At June 30, 2026 it held $1.1B in cash against $6.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Parabilis Medicines, Inc. does
Parabilis Medicines, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PBLS.
Latest SEC filings
What Parabilis Medicines, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 15, 2026
- September 2, 2026
- August 25, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- August 6, 2026Passive stake (5% or more) SCHEDULE 13G
- June 18, 2026Activist stake (5% or more) SCHEDULE 13D
- June 11, 2026
- June 10, 2026
Questions about PBLS
What does Parabilis Medicines, Inc. do?
Parabilis Medicines, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PBLS.
When did Parabilis Medicines, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 15, 2026.
Similar companies
Follow PBLS
Get an email when Parabilis Medicines, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PBLS: get an email when it filesWhere the numbers come from
Financial figures are the values Parabilis Medicines, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.